Advertisement
News
Advertisement

Gore Unveils Q50® PLUS Stent Graft Balloon Catheter

Thu, 01/17/2013 - 8:00am
The Associated Press

FLAGSTAFF, Ariz.--(BUSINESS WIRE)--Jan 17, 2013--W. L. Gore & Associates, Inc. (Gore) today announced availability of the new Q50 ® PLUS Stent Graft Balloon Catheter, featuring enhanced radial expansion force to aid in endograft modeling and sealing, and a new stopcock design to improve operator control. Designed for use with aortic stent grafts that treat abdominal aortic aneurysms (AAA), the Q50 PLUS Stent Graft Balloon Catheter is ideal for use with the flexibility of the GORE® EXCLUDER® AAA Endoprosthesis in challenging anatomies.

“The new enhancements allow for improved confidence in ensuring aortic stents fully expand and seal in both tortuous and straightforward vessels,” said Erin Moore, MD, Medical Director of Vascular and Endovascular Surgery at Baptist Heart Hospital, Jacksonville, Fla.

The new Q50 PLUS Stent Graft Balloon Catheter features the broadest balloon diameter range with the lowest available profile. With an improved stopcock design to enhance ease-of-use, the Q50 PLUS device provides exceptional balloon inflation control, optimized catheter pushability, and a tapered flexible tip to facilitate device passage. The inflated balloon diameter ranges from 10 to 50 mm, ensuring full expansion and sealing of aortic stent grafts. Available in 65 cm and 100 cm lengths in a 12 Fr introduction profile, the Q50 PLUS device is ideal for temporary occlusion of large vessels.

“The enhancements we’re rolling out in the Q50 PLUS Stent Graft Balloon Catheter underscore our dedication to providing the clinical community with the most sophisticated, minimally invasive alternatives to traditional treatment methods,” said Ryan Takeuchi, Gore Aortic Business Leader.

Gore is the exclusive US distributor of the Q50 PLUS Stent Graft Balloon Catheter for QXMédical, a medical device company based in Montreal, Canada.

ABOUT W. L. GORE & ASSOCIATES The Gore Medical Products Division has provided creative therapeutic solutions to complex medical problems for more than 35 years. During that time, more than 35 million innovative Gore Medical Devices have been implanted, saving and improving the quality of lives worldwide. The extensive Gore Medical family of products includes vascular grafts, endovascular and interventional devices, surgical meshes for hernia repair, soft tissue reconstruction, staple line reinforcement and sutures for use in vascular, cardiac, and general surgery. Gore was recently named one of the best companies to work for by Fortune magazine for the 15th consecutive year. For more information, visit www.goremedical.com.

About QXMédical, LLC QXMédical (QXM) is an innovative global medical device company committed to developing and manufacturing state-of-the-art solutions for both endovascular and cardiovascular markets. The company’s marketing, engineering and regulatory expertise allows rapid identification of clinical needs and accelerated product development and delivery. QXM’s product portfolio covers a wide platform of device technologies including balloon catheters, support catheters and access devices.

Headquartered in Montreal, Canada, the company’s research, development and manufacturing facilities are based in St. Paul, Minnesota. QXM serves a wide range of markets through various channels, including both direct sales and strategic partnerships. For more information, please visit www.qxmedical.com.

Products listed may not be available in all markets. Q50® is a trademark of QXMédical Inc. GORE®, EXCLUDER®, and designs are trademarks of W. L. Gore & Associates.

CONTACT: Chempetitive Group for W. L. Gore & Associates Erik Clausen or Rachel Lear 781-775-3640 GoreMedical@Chempetitive.com KEYWORD: UNITED STATES NORTH AMERICA CANADA ARIZONA MINNESOTA INDUSTRY KEYWORD: SURGERY HEALTH BIOTECHNOLOGY CARDIOLOGY HOSPITALS MEDICAL DEVICES MANUFACTURING ENGINEERING RESEARCH SCIENCE SOURCE: W. L. Gore & Associates, Inc. Copyright Business Wire 2013 PUB: 01/17/2013 08:00 AM/DISC: 01/17/2013 08:00 AM http://www.businesswire.com/news/home/20130117005132/

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading